This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2022 May 26;139(21):3103-3104.

doi: 10.1182/blood.2022015995.

A cauldron of choices

Manali Kamdar¹

Affiliations

PMID: 35616990
DOI: 10.1182/blood.2022015995

Free article

Editorial

A cauldron of choices

Manali Kamdar. Blood. 2022.

Free article

. 2022 May 26;139(21):3103-3104.

doi: 10.1182/blood.2022015995.

Author

Manali Kamdar¹

Affiliation

¹ University of Colorado Cancer Center.

PMID: 35616990
DOI: 10.1182/blood.2022015995

No abstract available

PubMed Disclaimer

Comment on

Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study.
Song Y, Zhou K, Zou D, Zhou J, Hu J, Yang H, Zhang H, Ji J, Xu W, Jin J, Lv F, Feng R, Gao S, Guo H, Zhou L, Huang J, Novotny W, Kim P, Yu Y, Wu B, Zhu J. Song Y, et al. Blood. 2022 May 26;139(21):3148-3158. doi: 10.1182/blood.2021014162. Blood. 2022. PMID: 35303070 Free PMC article. Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems